Researchers recently collaborated on a novel, highly specific strategy to treat type 1 diabetes (T1D) using a tagged beta cell transplant in tandem with localized immune protection provided by specialized immune cells also tagged with a complementary but inert targeting molecule.
Read more …Revolutionary bioengineering research may transform type 1 diabetes care, pave way for tackling...

More Articles …